Treatment- and immune-related adverse events of immune checkpoint inhibitors in esophageal or gastroesophageal junction cancer: A network meta-analysis of randomized controlled trials

OBJECTIVE: To systematically evaluate the safety and adverse event profiles of immune checkpoint inhibitors (ICIs) in patients with esophageal cancer (EPC) or gastroesophageal junction cancer (GEJC). METHODS: PubMed, Web of Science, Cochrane Library, and major conference proceedings were systematica...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jianqing, Huang, Bifen, Xiao, Lihua, Wu, Min, Li, Jiancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780048/
https://www.ncbi.nlm.nih.gov/pubmed/36568203
http://dx.doi.org/10.3389/fonc.2022.821626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780048/
https://www.ncbi.nlm.nih.gov/pubmed/36568203
http://dx.doi.org/10.3389/fonc.2022.821626

Ejemplares similares